Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 0 | $0 |
Sells | 631 | $399,440,398 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
26 Feb 2024 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | BASSLER BONNIE L | Director | 26 Feb 2024 | Sale | 854 | 979.25 | 836,280 | D |
03 Mar 2023 16:03 | REGN | REGENERON PHARMACEUTICALS Inc | MCCOURT MARION | EVP Commercial | 01 Mar 2023 | Sale | 1,100 | 759.89 | 835,879 | D |
02 Dec 2022 16:06 | REGN | REGENERON PHARMACEUTICALS Inc | MCCOURT MARION | EVP Commercial | 01 Dec 2022 | Sale | 1,100 | 756.19 | 831,809 | D |
15 Mar 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 14 Mar 2024 | Sale | 870 | 954.66 | 830,554 | D |
03 Feb 2023 16:13 | REGN | REGENERON PHARMACEUTICALS Inc | MCCOURT MARION | EVP Commercial | 01 Feb 2023 | Sale | 1,100 | 752.19 | 827,409 | D |
02 Nov 2022 16:03 | REGN | REGENERON PHARMACEUTICALS Inc | MCCOURT MARION | EVP Commercial | 01 Nov 2022 | Sale | 1,100 | 750 | 825,000 | D |
17 May 2024 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 15 May 2024 | Sale | 846 | 970.36 | 820,925 | D |
08 Nov 2022 16:00 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 07 Nov 2022 | Sale | 1,100 | 743.39 | 817,729 | D |
06 Dec 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 05 Dec 2023 | Sale | 973 | 819.57 | 797,442 | D |
07 Feb 2023 16:09 | REGN | REGENERON PHARMACEUTICALS Inc | BASSLER BONNIE L | Director | 03 Feb 2023 | Sale | 1,021 | 779 | 795,359 | D |
05 Jan 2023 16:22 | REGN | REGENERON PHARMACEUTICALS Inc | MCCOURT MARION | EVP Commercial | 03 Jan 2023 | Sale | 1,100 | 721.86 | 794,046 | D |
31 Jan 2024 16:52 | REGN | REGENERON PHARMACEUTICALS Inc | BASSLER BONNIE L | Director | 30 Jan 2024 | Sale | 827 | 959 | 793,093 | D |
02 Nov 2023 16:03 | REGN | REGENERON PHARMACEUTICALS Inc | MCCOURT MARION | EVP Commercial | 01 Nov 2023 | Sale | 1,000 | 783.91 | 783,910 | D |
08 Feb 2023 16:14 | REGN | REGENERON PHARMACEUTICALS Inc | MCCOURT MARION | EVP Commercial | 07 Feb 2023 | Sale | 1,000 | 769.04 | 769,040 | D |
17 May 2024 16:06 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 16 May 2024 | Sale | 790 | 972.22 | 768,054 | D |
17 May 2024 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 15 May 2024 | Sale | 784 | 972.5 | 762,440 | D |
17 May 2024 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 15 May 2024 | Sale | 782 | 966.29 | 755,639 | D |
04 Jan 2024 16:11 | REGN | REGENERON PHARMACEUTICALS Inc | BASSLER BONNIE L | Director | 03 Jan 2024 | Sale | 826 | 914 | 754,964 | D |
13 Sep 2022 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 12 Sep 2022 | Sale | 1,052 | 716.28 | 753,527 | D |
25 Nov 2022 13:07 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 23 Nov 2022 | Sale | 1,002 | 741.34 | 742,823 | D |
25 Nov 2022 13:07 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 23 Nov 2022 | Sale | 1,005 | 736.46 | 740,142 | D |
30 Dec 2022 16:10 | REGN | REGENERON PHARMACEUTICALS Inc | COLES N ANTHONY | Director | 28 Dec 2022 | Sale | 1,022 | 714.61 | 730,331 | D |
07 Nov 2022 16:05 | REGN | REGENERON PHARMACEUTICALS Inc | MCCOURT MARION | EVP Commercial | 04 Nov 2022 | Sale | 1,000 | 727.82 | 727,820 | D |
17 May 2024 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 15 May 2024 | Sale | 727 | 983.88 | 715,281 | D |
08 Sep 2022 16:06 | REGN | REGENERON PHARMACEUTICALS Inc | COLES N ANTHONY | Director | 06 Sep 2022 | Sale | 1,220 | 582.56 | 710,723 | D |
23 Aug 2023 16:03 | REGN | REGENERON PHARMACEUTICALS Inc | BASSLER BONNIE L | Director | 21 Aug 2023 | Sale | 853 | 829 | 707,137 | D |
16 Feb 2024 16:15 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 14 Feb 2024 | Sale | 750 | 939.6 | 704,700 | D |
15 Nov 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 14 Nov 2023 | Sale | 877 | 801.56 | 702,968 | D |
15 Mar 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 14 Mar 2024 | Sale | 730 | 957.35 | 698,866 | D |
25 Nov 2022 13:07 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 23 Nov 2022 | Sale | 944 | 738.57 | 697,210 | D |
03 Oct 2022 16:05 | REGN | REGENERON PHARMACEUTICALS Inc | TESSIER-LAVIGNE MARC | Director | 29 Sep 2022 | Sale | 1,009 | 689.56 | 695,766 | D |
06 Dec 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 05 Dec 2023 | Sale | 829 | 816.46 | 676,845 | D |
11 Aug 2023 16:13 | REGN | REGENERON PHARMACEUTICALS Inc | BASSLER BONNIE L | Director | 10 Aug 2023 | Sale | 853 | 789 | 673,017 | D |
23 Aug 2023 16:03 | REGN | REGENERON PHARMACEUTICALS Inc | STAHL NEIL | EVP Research and Development | 22 Aug 2023 | Sale | 782 | 842.16 | 658,569 | D |
05 Jul 2022 16:03 | REGN | REGENERON PHARMACEUTICALS Inc | MCCOURT MARION | EVP Commercial | 01 Jul 2022 | Sale | 1,100 | 587.76 | 646,536 | D |
25 Aug 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 24 Aug 2023 | Sale | 759 | 843.31 | 640,072 | D |
02 Aug 2022 16:28 | REGN | REGENERON PHARMACEUTICALS Inc | MCCOURT MARION | EVP Commercial | 01 Aug 2022 | Sale | 1,100 | 581.53 | 639,683 | D |
17 May 2024 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 15 May 2024 | Sale | 647 | 985.62 | 637,696 | D |
02 Sep 2022 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | MCCOURT MARION | EVP Commercial | 01 Sep 2022 | Sale | 1,100 | 577.62 | 635,382 | D |
13 Sep 2022 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 12 Sep 2022 | Sale | 861 | 715.39 | 615,951 | D |
08 Sep 2022 16:06 | REGN | REGENERON PHARMACEUTICALS Inc | COLES N ANTHONY | Director | 06 Sep 2022 | Sale | 1,045 | 583.16 | 609,402 | D |
15 Nov 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 14 Nov 2023 | Sale | 752 | 794.57 | 597,517 | D |
16 Feb 2024 16:15 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 14 Feb 2024 | Sale | 620 | 944.3 | 585,466 | D |
25 Nov 2022 13:07 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 23 Nov 2022 | Sale | 780 | 744.56 | 580,757 | D |
12 Feb 2024 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | FENIMORE CHRISTOPHER R. | SVP Finance & CFO | 09 Feb 2024 | Sale | 600 | 955 | 573,000 | D |
08 Feb 2024 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | STAHL NEIL | EVP Research and Development | 07 Feb 2024 | Sale | 601 | 949.45 | 570,619 | D |
07 Feb 2023 16:09 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 03 Feb 2023 | Sale | 739 | 764.5 | 564,966 | D |
27 Mar 2023 16:41 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | President and Chief Scientific | 23 Mar 2023 | Sale | 700 | 806.47 | 564,529 | I |
25 Aug 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 24 Aug 2023 | Sale | 667 | 838.37 | 559,193 | D |
15 Mar 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 14 Mar 2024 | Sale | 576 | 953.77 | 549,372 | D |
14 Dec 2023 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | BASSLER BONNIE L | Director | 13 Dec 2023 | Sale | 610 | 870 | 530,700 | D |
25 Aug 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 24 Aug 2023 | Sale | 625 | 836.32 | 522,700 | D |
15 Mar 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 14 Mar 2024 | Sale | 545 | 955.54 | 520,769 | D |
25 Aug 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 24 Aug 2023 | Sale | 617 | 842.66 | 519,921 | D |
27 Mar 2023 16:41 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | President and Chief Scientific | 23 Mar 2023 | Sale | 642 | 803.3 | 515,719 | I |
25 Nov 2022 13:07 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 23 Nov 2022 | Sale | 686 | 735.57 | 504,601 | D |
28 Feb 2024 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | SING GEORGE L | Director | 26 Feb 2024 | Sale | 500 | 995 | 497,500 | D |
17 Aug 2022 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 16 Aug 2022 | Sale | 766 | 648.78 | 496,965 | D |
28 Feb 2024 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | SING GEORGE L | Director | 26 Feb 2024 | Sale | 500 | 990 | 495,000 | D |
17 May 2024 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 15 May 2024 | Sale | 504 | 979.87 | 493,854 | D |
26 Feb 2024 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | SING GEORGE L | Director | 23 Feb 2024 | Sale | 500 | 985 | 492,500 | D |
15 Mar 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 14 Mar 2024 | Sale | 512 | 959.36 | 491,192 | D |
30 Dec 2022 16:10 | REGN | REGENERON PHARMACEUTICALS Inc | COLES N ANTHONY | Director | 28 Dec 2022 | Sale | 679 | 710.63 | 482,518 | D |
08 Sep 2022 16:06 | REGN | REGENERON PHARMACEUTICALS Inc | COLES N ANTHONY | Director | 06 Sep 2022 | Sale | 822 | 581.44 | 477,944 | D |
03 Oct 2022 16:05 | REGN | REGENERON PHARMACEUTICALS Inc | TESSIER-LAVIGNE MARC | Director | 29 Sep 2022 | Sale | 692 | 690.65 | 477,930 | D |
12 Feb 2024 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | SING GEORGE L | Director | 09 Feb 2024 | Sale | 500 | 955 | 477,500 | D |
12 Feb 2024 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | SING GEORGE L | Director | 08 Feb 2024 | Sale | 500 | 945 | 472,500 | D |
25 Nov 2022 13:07 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 23 Nov 2022 | Sale | 629 | 747.28 | 470,039 | D |
13 Sep 2022 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 12 Sep 2022 | Sale | 647 | 717.59 | 464,281 | D |
12 Feb 2024 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | FENIMORE CHRISTOPHER R. | SVP Finance & CFO | 09 Feb 2024 | Sale | 487 | 951.39 | 463,327 | D |
15 Mar 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 14 Mar 2024 | Sale | 477 | 958.34 | 457,128 | D |
17 Aug 2022 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 16 Aug 2022 | Sale | 701 | 647.73 | 454,059 | D |
12 Sep 2022 16:31 | REGN | REGENERON PHARMACEUTICALS Inc | BASSLER BONNIE L | Director | 09 Sep 2022 | Sale | 609 | 741 | 451,269 | D |
02 Dec 2022 16:05 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 02 Dec 2022 | Sale | 582 | 756.5 | 440,283 | D |
08 Aug 2022 16:11 | REGN | REGENERON PHARMACEUTICALS Inc | STAHL NEIL | EVP Research and Development | 05 Aug 2022 | Sale | 724 | 607.47 | 439,808 | D |
03 Oct 2022 16:05 | REGN | REGENERON PHARMACEUTICALS Inc | TESSIER-LAVIGNE MARC | Director | 29 Sep 2022 | Sale | 637 | 688.71 | 438,708 | D |
17 May 2024 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 15 May 2024 | Sale | 442 | 986.4 | 435,989 | D |
05 Oct 2022 16:11 | REGN | REGENERON PHARMACEUTICALS Inc | MCCOURT MARION | EVP Commercial | 03 Oct 2022 | Sale | 600 | 705.39 | 423,234 | D |
15 Mar 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 14 Mar 2024 | Sale | 444 | 952.4 | 422,866 | D |
25 Aug 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | POON CHRISTINE A | Director | 23 Aug 2023 | Sale | 500 | 841.05 | 420,525 | D |
16 Feb 2024 16:15 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 14 Feb 2024 | Sale | 439 | 937.94 | 411,756 | D |
13 Sep 2022 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 12 Sep 2022 | Sale | 572 | 713.67 | 408,219 | D |
08 Sep 2022 16:06 | REGN | REGENERON PHARMACEUTICALS Inc | COLES N ANTHONY | Director | 06 Sep 2022 | Sale | 688 | 580.44 | 399,343 | D |
08 Feb 2023 16:15 | REGN | REGENERON PHARMACEUTICALS Inc | BROWN MICHAEL S | Director | 06 Feb 2023 | Sale | 500 | 797 | 398,500 | I |
17 May 2024 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 15 May 2024 | Sale | 406 | 971.28 | 394,340 | D |
16 Nov 2022 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 15 Nov 2022 | Sale | 532 | 731.49 | 389,153 | D |
26 Dec 2023 16:08 | REGN | REGENERON PHARMACEUTICALS Inc | FENIMORE CHRISTOPHER R. | SVP Controller | 21 Dec 2023 | Sale | 456 | 843.79 | 384,768 | D |
03 Oct 2022 16:05 | REGN | REGENERON PHARMACEUTICALS Inc | TESSIER-LAVIGNE MARC | Director | 29 Sep 2022 | Sale | 554 | 691.59 | 383,141 | D |
16 Nov 2022 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 15 Nov 2022 | Sale | 521 | 729.37 | 380,002 | D |
10 Nov 2022 16:00 | REGN | REGENERON PHARMACEUTICALS Inc | BROWN MICHAEL S | Director | 08 Nov 2022 | Sale | 500 | 748.49 | 374,245 | I |
08 Aug 2022 16:11 | REGN | REGENERON PHARMACEUTICALS Inc | STAHL NEIL | EVP Research and Development | 05 Aug 2022 | Sale | 610 | 608.7 | 371,307 | D |
17 May 2024 16:06 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 16 May 2024 | Sale | 379 | 978.18 | 370,730 | D |
17 May 2024 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 15 May 2024 | Sale | 373 | 988.36 | 368,658 | D |
16 Feb 2024 16:15 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 14 Feb 2024 | Sale | 375 | 950.45 | 356,419 | D |
05 Oct 2022 16:11 | REGN | REGENERON PHARMACEUTICALS Inc | MCCOURT MARION | EVP Commercial | 03 Oct 2022 | Sale | 500 | 705.39 | 352,695 | D |
08 Sep 2022 16:06 | REGN | REGENERON PHARMACEUTICALS Inc | COLES N ANTHONY | Director | 06 Sep 2022 | Sale | 602 | 584.57 | 351,911 | D |
05 Mar 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | MCCOURT MARION | EVP Commercial | 01 Mar 2024 | Sale | 358 | 967.5 | 346,365 | D |
17 Aug 2022 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 16 Aug 2022 | Sale | 537 | 641.47 | 344,469 | D |
08 Aug 2022 16:11 | REGN | REGENERON PHARMACEUTICALS Inc | STAHL NEIL | EVP Research and Development | 05 Aug 2022 | Sale | 535 | 616.4 | 329,774 | D |
12 Feb 2024 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | FENIMORE CHRISTOPHER R. | SVP Finance & CFO | 09 Feb 2024 | Sale | 344 | 950.49 | 326,969 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)